Related Experiment Video
Updated: Jul 4, 2026
07:53
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 11, 2010
Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.
1Division of Cytogenetics, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. zhang0jb@yahoo.com
Cancer Letters
|August 25, 2001
Summary
Researchers identified two phages, t147 and t160, that bind to neuroblastoma cells using phage display. These phages, displaying peptides p147 and p160, show potential for targeted drug delivery in specific tumor systems.
Area of Science:
- Biotechnology
- Molecular Biology
- Oncology
Background:
- Phage display is a powerful technique for identifying molecular interactions.
- Targeting cancer cells remains a significant challenge in drug development.
Purpose of the Study:
- To isolate and characterize peptides that bind to human neuroblastoma cells using phage display.
- To evaluate the potential of these peptides for targeted drug delivery.
Main Methods:
- Utilized random peptide phage display libraries with the WAC 2 neuroblastoma cell line as the target.
- Isolated and characterized two bacteriophages, t147 and t160, displaying peptides p147 and p160.
- Investigated phage binding, internalization mechanisms (receptor-mediated endocytosis), and binding specificity across various cell lines.
Main Results:
- Phages t147 and t160 specifically bind to neuroblastoma cells, with binding mediated by their displayed peptides.
- t147 primarily remains on the cell surface, while t160 is largely internalized via receptor-mediated endocytosis.
- Phage t147 shows broader binding to various tumor cell lines (neuroblastoma, breast cancer, glioblastoma, C-cell carcinoma) compared to non-tumor cells. Phage t160 binds to neuroblastoma and some breast cancer cell lines.
Conclusions:
- The identified peptides p147 and p160 provide a basis for targeted drug delivery in specific experimental or natural tumor systems.
- While not exhibiting narrow tissue specificity, the differential binding profiles suggest potential for selective targeting of certain cancer types.
